(Q29617986)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

1 reference

McLean CA

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

Cherny RA

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

Fraser FW

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

Fuller SJ

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

Smith MJ

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

Beyreuther K

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

Bush AI

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

Masters CL

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

December 1999

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

volume

46

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

page(s)

860-6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

30 April 2017

issue

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=10589538

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Neuritic pathology and dementia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Correlations of synaptic and pathological markers with cognition of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Amyloid beta-protein deposition in the leptomeninges and cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Amyloid beta-protein (A beta) accumulation in the putamen and mammillary body during aging and in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Diagnosis and staging of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

The Presence of Amyloid β-Protein in the Detergent-Insoluble Membrane Compartment of Human Neuroblastoma Cells†

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Apolipoprotein E, a gene with complex biological interactions in the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Alpha-2 macroglobulin is genetically associated with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

Mutant presenilin 2 transgenic mouse: effect on an age-dependent increase of amyloid beta-protein 42 in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199912%2946%3A6%3C860%3A%3AAID-ANA8%3E3.0.CO%3B2-M

10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

510476

Fatcat ID

release_4nsc2l64i5bzxdtpjpr3wcztnm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4nsc2l64i5bzxdtpjpr3wcztnm

mapped directly with Wikidata item

24 November 2022

based on heuristic

OpenCitations bibliographic resource ID

510476

1 reference